MRMD: Is This Cannabis Stock About to Ignite?

 There is another cannabis stock that has recently caught my attention, and that stock is MariMed (MRMD). While it may not be one of the more widely followed names in the cannabis sector, I think the recent price and volume action is worth paying attention to.

If you look at the daily chart above, one of the first things that jumps out at me is the heavy volume that came into the stock on Thursday and Friday. Whenever I see a sudden increase in volume like this, I take notice. Volume is one of the most important pieces of information on a chart because it can give me an indication that something has changed beneath the surface.

What makes the recent action even more interesting to me is what happened on the weekly chart. MRMD has reclaimed a key support level on heavy volume and, perhaps more importantly, closed right at the high of the week. In my opinion, that is a very bullish development.

I tend to look at moves like this differently depending on where they occur and how they develop. At this point, I would characterize the recent move as more of an igniting move than a climactic move. In other words, I don't necessarily view the surge in volume as evidence that everyone is rushing to get out. Instead, I think there is a possibility that we are seeing the beginning of something rather than the end of a move.

The company's recent earnings report gives me another reason to keep MRMD on my radar.

MariMed reported quarterly sales of $41.925 million, which was above the analyst consensus estimate of $39.8 million. Revenue also increased 5.84% from $39.611 million during the same period last year. Earnings came in at a loss of $0.01 per share, which was in line with analyst expectations.

What I found particularly encouraging was some of the operational commentary. Wholesale revenue increased 6% sequentially, while retail revenue increased 7% sequentially. Revenue increased at 12 of the company's 13 Thrive Dispensary locations, and transactions across the retail network also increased 7%.

Another thing that caught my attention was the company's branded product business. Management said distribution of its branded products increased to 85% of available storefronts on a trailing 12-month basis. Betty's Eddies remained the number-one-selling edible brand across MariMed's core states, while Vibations remained a top-10 brand.

Perhaps most importantly, adjusted gross margin held steady at 40% sequentially. In an industry where many operators continue to struggle with pricing pressure, I think maintaining profitability while continuing to grow revenue is encouraging.

None of this guarantees that MRMD is about to embark on a major rally. I've learned not to make that assumption with cannabis stocks. But when I combine improving operating results with a stock reclaiming an important support level, heavy volume, and a weekly close at the high, I think MRMD deserves a closer look.

For now, I'm watching it closely. If this volume continues to come into the stock and MRMD can build on this breakout, I think we could be looking at the early stages of a much more interesting move.

TRLV Continues to Flex Its Relative Strength

 

Well, it’s been a few weeks since my last post on cannabis stocks, so I figured it was time to give a little update. And so far, I have to say that things are working out pretty much exactly as I had hoped.

Back on July 31st, which is Point A on the chart, I posted about the reasons I was turning bullish on TRLV. At the time, I was seeing some very encouraging signs, particularly when it came to relative strength. Since then, TRLV has put together a really impressive move.

If you look at the daily chart above on the left, you can see the beautiful rally that has taken place over the past several weeks. The stock has continued to grind higher, producing a series of green candles along the way. What really caught my attention, however, is what has happened over the last three trading days. We’ve seen multiple strong green candles accompanied by expanding volume. That is exactly the type of price and volume action I like to see when a stock is beginning to establish itself as a leader.

One of my favorite tools for identifying potential opportunities is relative strength. Rather than simply looking at whether a stock is going up or down, I want to know how that stock is performing compared with its peers. In this case, I’ve been comparing TRLV to the MSOS cannabis ETF.

If you look at the ratio line on the chart above on the left, you can see something particularly encouraging, TRLV versus MSOS has broken out to a new high. This is precisely what I was anticipating when I turned bullish on the stock back in July.

To me, this is an important confirmation that TRLV is indeed emerging as one of the leading stocks in the cannabis sector. The price action is strong, volume is expanding, and now the relative strength line is confirming that TRLV is outperforming the broader cannabis group.

The next level I’m watching closely is the previous swing high of $13.28, which was established in June. I’d like to see this rally continue and eventually challenge that level. As we get closer to $13.28, I’ll be watching volume carefully. Ideally, I’d like to see volume continue to expand as the stock approaches and potentially breaks through that resistance.

Of course, nothing moves straight up forever, so a pullback wouldn’t surprise me at all. In fact, if we do get a healthy pullback, I would view that as a potential opportunity to add to my long position, assuming the underlying strength remains intact.

If you’d like to read my original post from last month, you can do so by clicking “Don’t Ignore This Bullish Signal in TRLV.”

Is Tilray Finally Ready to Wake Up?

 

Could the long awaited turnaround in Tilray finally be getting underway? I'm not ready to declare victory just yet, but I have to admit the chart is beginning to look much more interesting than it has in a very long time.

Take a look at the daily chart above. Over the past two trading days, TLRY has posted two of the strongest bullish sessions we've seen in many months. Just as important as the price action is the volume behind the move. Buying volume has surged, giving us the heaviest green volume days we've seen in quite some time. Whenever I see unusually heavy volume accompanying a strong advance, I pay attention because it often signals that institutional investors may be accumulating shares.

Now shift your attention to the weekly chart on the right. One thing immediately stands out: TLRY has formed a bullish outside reversal bar. That's a pattern I always like to see after a prolonged decline because it tells me buyers stepped in aggressively after sellers initially pushed prices lower. Even more encouraging is where this reversal occurred. The pattern developed right at a major long-term support area, which makes the signal much more meaningful.

Momentum is also beginning to improve. The weekly MACD, one of my favorite momentum indicators, has just generated its first bullish crossover in many months. By itself, a MACD crossover doesn't guarantee higher prices, but when it occurs alongside a bullish reversal pattern, expanding volume, and major support, it certainly gets my attention.

Speaking of volume, this past week's buying volume was the strongest bullish weekly volume we've seen since September 2025. That tells me this wasn't just another ordinary bounce. Someone was buying, and they were buying aggressively.

Fundamentally, Tilray also gave investors something to think about with its recently released fiscal 2026 earnings. The company reported record annual revenue of $915.5 million, an 11% increase over last year. Adjusted EBITDA climbed to $61.1 million, while gross profit also reached a record level. Looking ahead, management expects adjusted EBITDA to increase again in fiscal 2027 to between $68 million and $75 million. While these numbers don't suddenly transform Tilray into a high-growth company, they do suggest management is making steady progress and that the business is moving in the right direction.

From my perspective, improving fundamentals combined with improving technicals make for an interesting combination.

As for my trading plan, it's very straightforward. A break above last week's high of $4.56 will likely get me long. My stop would be below the major support area near $3.50, giving me approximately $1.00 of downside risk.

Could the trade fail? Absolutely. There are never any guarantees in the stock market. But when I weigh the relatively small amount of risk against the upside potential, especially considering how explosive Tilray has been during previous cannabis rallies, I think it's a risk worth taking. As always, I'm sharing what I'm seeing before the move, not after the fact. Whether TLRY becomes one of the next leaders remains to be seen, but it's definitely a stock I'll be watching very closely

For more analysis and market insights, visit my homepage 

Don't Ignore This Bullish Signal in TRLV

 

Well, another month has come to a close, and unfortunately it was another disappointing one for cannabis investors. If you've been following my blog for a while, you know I'm a big believer in seasonality. Historically, July has been one of the most bullish months of the year for marijuana stocks, so I came into the month expecting the sector to finally show some life. Instead, we got the exact opposite.

Rather than rallying, cannabis stocks spent most of July drifting lower and breaking important support levels along the way. Needless to say, that wasn't what I expected. Does that change my long-term outlook? Not at all.

The truth is, nobody knows when this sector is finally going to wake up. It could be next week, next month, or several months from now. That's simply the reality of investing in a beaten down sector. But one thing I have learned over the years is that the biggest moves usually begin when the majority of investors have already given up hope. That's why I believe it's so important to have a game plan before the rally begins instead of trying to figure things out after prices have already exploded higher.

One cannabis stock that continues to stand out to me is TRLV. If you look at the daily chart above, you'll notice there really isn't much to get excited about. During the month of July, the stock basically moved sideways with a slight downward bias. If you were only looking at the price chart, you'd probably move on to something else.

But that's exactly why I spend so much time studying relative strength.

Now take a look at the ratio chart comparing TRLV to MSOS. Suddenly, the picture changes. While the stock itself has gone nowhere, the ratio line has been climbing steadily higher. In fact, it's now sitting at a new five-week high. To me, that's a very encouraging sign because it tells me TRLV is quietly outperforming the cannabis ETF even though the sector as a whole continues to struggle.

I've said it many times before: the strongest stocks usually reveal themselves before they actually begin making major price advances. Relative strength often gives us an early clue about where institutional money may be flowing, and right now TRLV is showing exactly the kind of behavior I like to see.

My expectation is that when MSOS finally turns higher and I do believe that day is coming, TRLV has an excellent chance of leading the cannabis sector. That's one of the reasons it remains one of my favorite cannabis holdings, and I continue to believe much higher prices are ahead.

I also want to point out something that's important. Notice the timing of this post. I'm not writing about TRLV after it has already made a huge move or after everyone on social media is talking about it. I'm sharing what I'm seeing before the breakout happens. Will I be right? Of course, there's no guarantee. The market has a way of humbling all of us. But if you're looking for a cannabis stock that is quietly showing leadership while everyone else is focused on the weakness in the sector, I believe TRLV deserves a spot at the top of your watch list.

For more analysis and market insights, visit my homepage 

Why I'm Watching CURLD Closely Heading Into July

 

Above is a daily chart of CURLD, and in the lower pane you'll see the MACD indicator. One of the patterns I've noticed for this stock is that when the MACD is below the zero line and then produces a bullish crossover, the stock often goes on to rally. It's certainly not a perfect signal, but it has proven to be a useful tool for identifying potential turning points after periods of weakness.

If you look at the chart, you'll see several examples of this setup. At points A, B, C, and D, the MACD crossed higher while still below the zero line. In each case, the stock responded positively. Point C spent more time moving sideways than trending higher, but the bullish crossover still marked the end of the previous decline. The other signals led to much stronger advances.

Now we're seeing a very similar setup develop once again.

The MACD remains below the zero line, but it's beginning to curl upward. If it completes a bullish crossover, I'll be paying very close attention. On its own, I believe this setup has better than a 50% chance of producing a profitable move. However, I've found that no single indicator should ever be relied upon by itself. Instead, I like to stack multiple factors in my favor before committing capital.

That's where seasonality comes into the picture.

Above is a seasonal table for CURLD, and one statistic immediately jumps off the page. Historically, July has been the stock's strongest month, producing a bullish move approximately 85% of the time. Granted, the historical data only goes back to 2018, so we're dealing with a relatively small sample size. Even with that limitation, July stands out by a wide margin as the most favorable month on the calendar for this stock.

When I combine those two factors, a potential MACD buy signal and a very strong seasonal tailwind, I believe the probability of success increases meaningfully. Neither one guarantees the stock will rally, but together they create a setup that deserves my attention.

This is exactly how I like to approach trading. Rather than relying on a single indicator or making emotional decisions, I prefer to look for situations where technical analysis, seasonality, and probability all point in the same direction. The more pieces of evidence I can gather, the more confidence I have in taking a trade.

I'm not blindly buying just because the calendar is turning to July. I still want to see confirmation from the MACD and, ideally, some improvement in price action before getting involved. If those pieces begin to fall into place over the next several trading sessions, CURLD could become one of the more interesting cannabis stocks on my watch list.

I'll be stalking this trade closely in the days ahead to see if everything comes together.

For more analysis and market insights, visit my homepage